Journal of Oral Pathology and Medicine · 2021 · 27 citations · 5 references
Veterinary MedicineOncologyOral PathologyMolecular OncologyNeoplasiaOral OncologyMalignant Oral TumorsOdontogenic TumorsOral Cancer PathologyOral Cavity CancerOral NeoplasiaAdenomatoid TumorBraf V600 MutationsBraf V600e MutationKras Mutation AnalysisKras Mutation TestingMalignant Epithelial NeoplasmOdontogenic Tumor GeneticsOdontogenic Tumor Molecular Pathogenesis
BACKGROUND: Adenoid ameloblastoma is a rare epithelial neoplasm, histologically characterized by the presence of ameloblastoma-like features, duct-like structures, epithelial whorls, and cribriform architecture. Dentinoid material is usually present. Some advocate adenoid ameloblastoma is an ameloblastoma variant. However, there are overlapping features not only with ameloblastoma, but also with adenomatoid odontogenic tumor. Most ameloblastomas are characterized by the presence of BRAF p.V600E mutations and adenomatoid odontogenic tumors harbor signature KRAS mutations. The molecular features of adenoid ameloblastoma remain unknown. METHODS: Nine adenoid ameloblastoma cases were screened by TaqMan allele-specific qPCR to assess BRAF p.V600E, ameloblastoma signature mutation, and KRAS p.G12V and p.G12R, adenomatoid odontogenic tumor signature mutations. RESULTS: BRAF and KRAS mutations were not detected in any of the adenoid ameloblastoma cases. CONCLUSION: The molecular results support adenoid ameloblastoma as an entity distinct from adenomatoid odontogenic tumor and ameloblastoma.
5
High frequency of <scp>BRAF</scp><scp>V600E</scp> mutations in ameloblastoma
Kari J. Kurppa, Javier Catón, Peter R. Morgan et al. · The Journal of Pathology · 2013 · 308 citations · Full text
Medicine, Oncology, Oral Pathology +17